Factors associated with kidney disease progression and mortality in a referred CKD population

American Journal of Kidney Diseases

Volumn 56, Issue 6, 2010, Pages 1072-1081

  Hoefield, Richard A ^a,c   Kalra, Philip A ^a   Baker, Patricia ^a   Lane, Beverley ^a   New, John P ^a   O'Donoghue, Donal J ^a   Foley, Robert N ^b   Middleton, Rachel J ^a  

^a UNIVERSITY OF MANCHESTER   (United Kingdom)

^b MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

^c Vascular Research Group   (United States)

Author keywords

Chronic kidney disease (CKD); Epidemiology; Estimated glomerular filtration rate (eGFR); Mortality; Progression

Indexed keywords

ADULT; AGED; ARTICLE; CHRONIC KIDNEY DISEASE; COHORT ANALYSIS; DEATH; DISEASE COURSE; FEMALE; FOLLOW UP; GLOMERULUS FILTRATION RATE; HUMAN; KIDNEY FUNCTION; MAJOR CLINICAL STUDY; MALE; MORTALITY; RENAL REPLACEMENT THERAPY; UNITED KINGDOM;

AGED; CHRONIC DISEASE; COHORT STUDIES; DISEASE PROGRESSION; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; KIDNEY DISEASES; MALE; MARKOV CHAINS; MIDDLE AGED; MODELS, STATISTICAL; PROSPECTIVE STUDIES; REFERRAL AND CONSULTATION; RENAL REPLACEMENT THERAPY; RISK FACTORS;

EID: 78649442787     PISSN: 02726386     EISSN: None     Source Type: Journal    
DOI: 10.1053/j.ajkd.2010.06.010     Document Type: Article

References (33)

1. R.N. Foley, A.M. Murray, and S. Li Chronic kidney disease and the risk for cardiovascular disease, renal replacement, and death in the United States Medicare population, 1998 to 1999 J Am Soc Nephrol 16 2 2005 489 495
2. A.S. Go, G.M. Chertow, D. Fan, C.E. McCulloch, and C.Y. Hsu Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization N Engl J Med 351 13 2004 1296 1305
3. A.X. Garg, W.F. Clark, R.B. Haynes, and A.A. House Moderate renal insufficiency and the risk of cardiovascular mortality: results from the NHANES I Kidney Int 61 4 2002 1486 1494
4. P. Muntner, J. He, L. Hamm, C. Loria, and P.K. Whelton Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States J Am Soc Nephrol 13 3 2002 745 753
5. M.G. Shlipak, L.F. Fried, and C. Crump Cardiovascular disease risk status in elderly persons with renal insufficiency Kidney Int 62 3 2002 997 1004
6. J.P. Lash, A.S. Go, and L.J. Appel Chronic Renal Insufficiency Cohort (CRIC) Study: baseline characteristics and associations with kidney function Clin J Am Soc Nephrol 4 8 2009 1302 1311
7. M.L. Thorp, L. Eastman, D.H. Smith, and E.S. Johnson Managing the burden of chronic kidney disease Dis Manag 9 2 2006 115 121
8. Y.L. Chiu, K.L. Chien, S.L. Lin, Y.M. Chen, T.J. Tsai, and K.D. Wu Outcomes of stage 3-5 chronic kidney disease before end-stage renal disease at a single center in Taiwan Nephron Clin Pract 109 3 2008 c109 c118
9. A. Levin, O. Djurdjev, M. Beaulieu, and L. Er Variability and risk factors for kidney disease progression and death following attainment of stage 4 CKD in a referred cohort Am J Kidney Dis 52 4 2008 661 671
10. A.S. Levey, J.P. Bosch, J.B. Lewis, T. Greene, N. Rogers, and D. Roth A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation Modification of Diet in Renal Disease Study Group Ann Intern Med 130 6 1999 461 470
11. National Institute for Health and Clinical Excellence CG73 Chronic Kidney Disease NICE Guideline www.nice.org.uk/nicemedia/pdf/CG073FullGuideline.pdf Accessed January 14, 2010
12. JBS 2 Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice Heart 91 suppl 5 2005 v1 v52
13. National Kidney Foundation K/DOQI Part 4. Definition and classification of stages of chronic kidney disease Am J Kidney Dis 39 suppl 1 2002 S46 S75
14. P. Muntner, J. He, L. Hamm, C. Loria, and P.K. Whelton Renal insufficiency and subsequent death resulting from cardiovascular disease in the United States J Am Soc Nephrol 13 3 2002 745 753
15. B. Stengel, P. Loury, and M. Froissart Long-term outcome in the elderly with chronic kidney disease (CKD) in the general population [abstract] Nephrol Dial Transplant 22 suppl 6 2007 vi226
16. Mafham MM, Emberson J, Landray M. Meta-analysis of observational studies relating estimated glomerular filtration rate to risk of death or major cardiovascular events. Program and abstracts of the American Society of Nephrology Renal Week. November 13-19, 2006; San Diego, CA.
17. H.I. Feldman, L.J. Appel, and G.M. Chertow The Chronic Renal Insufficiency Cohort (CRIC) Study: design and methods J Am Soc Nephrol 14 7 suppl 2 2003 S148 S153
18. D.C. Wheeler, J.N. Townend, and M.J. Landray Cardiovascular risk factors in predialysis patients: baseline data from the Chronic Renal Impairment in Birmingham (CRIB) Study Kidney Int Suppl 84 2003 S201 S203
19. Emberson J. Prediction of end-stage renal disease and mortality among patients with pre-dialysis chronic kidney disease: The Chronic Renal Impairment in Birmingham (CRIB) cohort. Paper presented as an abstract at: British Renal Society/Renal Association meeting. May 14, 2008; Glasgow, UK.
20. C.D. Agardh, J. Garcia-Puig, B. Charbonnel, B. Angelkort, and A.H. Barnett Greater reduction of urinary albumin excretion in hypertensive type II diabetic patients with incipient nephropathy by lisinopril than by nifedipine J Hum Hypertens 10 3 1996 185 192
21. T. Chuahirun, and D.E. Wesson Cigarette smoking predicts faster progression of type 2 established diabetic nephropathy despite ACE inhibition Am J Kidney Dis 39 2 2002 376 382
22. H.E. Lebovitz, T.B. Wiegmann, and A. Cnaan Renal protective effects of enalapril in hypertensive NIDDM: role of baseline albuminuria Kidney Int Suppl 45 1994 S150 S155
23. S.R. Orth, E. Ritz, and R.W. Schrier The renal risks of smoking Kidney Int 51 6 1997 1669 1677
24. P. Ruggenenti, A. Fassi, and A.P. Ilieva Preventing microalbuminuria in type 2 diabetes N Engl J Med 351 19 2004 1941 1951
25. D. Ansell, P. Roderick, A. Hodsman, D. Ford, R. Steenkamp, and C. Tomson UK Renal Registry 11th Annual Report (December 2008): chapter 7 survival and causes of death of UK adult patients on renal replacement therapy in 2007: national and centre-specific analyses Nephron Clin Pract 111 suppl 1 2009 c113 c139
26. W.F. Owen, and E.G. Lowrie C-Reactive protein as an outcome predictor for maintenance hemodialysis patients Kidney Int 54 2 1998 627 636
27. A.I. Adler, R.J. Stevens, S.E. Manley, R.W. Bilous, C.A. Cull, and R.R. Holman Development and progression of nephropathy in type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS 64) Kidney Int 63 1 2003 225 232
28. A.J. Collins, S. Li, D.T. Gilbertson, J. Liu, S.C. Chen, and C.A. Herzog Chronic kidney disease and cardiovascular disease in the Medicare population Kidney Int Suppl 87 2003 S24 S31
29. E. Casiglia, A. Mazza, and V. Tikhonoff Weak effect of hypertension and other classic risk factors in the elderly who have already paid their toll J Hum Hypertens 16 1 2002 21 31
30. W.B. Kannel, R.B. D'Agostino, and H. Silbershatz Blood pressure and cardiovascular morbidity and mortality rates in the elderly Am Heart J 134 4 1997 758 763
31. A. Menotti, I. Mulder, and A. Nissinen Cardiovascular risk factors and 10-year all-cause mortality in elderly European male populations; the FINE Study Finland, Italy, Netherlands, Elderly Eur Heart J 22 7 2001 573 579
32. C. Chiurchiu, G. Remuzzi, and P. Ruggenenti Angiotensin-converting enzyme inhibition and renal protection in nondiabetic patients: the data of the meta-analyses J Am Soc Nephrol 16 suppl 1 2005 S58 S63
33. T.H. Jafar, P.C. Stark, and C.H. Schmid Proteinuria as a modifiable risk factor for the progression of non-diabetic renal disease Kidney Int 60 3 2001 1131 1140